Seth Harlem

Seth Harlem

Taithera, Inc.

2016-2017

Technologies

Therapeutic

Indication

Musculoskeletal Disorders

Oncology

Executive Summary

View/Download

Taithera is a revolutionary nanomedicine bone targeted drug delivery
controlled release platform technology for the treatment of musculoskeletal
conditions focused initially on fracture healing & bone cancer
(osteosarcoma is our first oncology target).

Newsletter Signup

Corporate Supporters

Community Service Providers